Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BodyMetRx is a specialized healthcare services company focused on providing clinical-grade body composition and metabolic health assessments. The company utilizes advanced diagnostic technologies, including Dual-Energy X-ray Absorptiometry (DEXA) scans, to provide precise measurements of body fat, lean muscle mass, and bone mineral density. In addition to body composition analysis, BodyMetRx offers Resting Metabolic Rate (RMR) testing and VO2 Max evaluations to help clients understand their unique caloric needs and cardiovascular fitness levels. These data-driven insights are used to create personalized nutrition and exercise programs for athletes, fitness enthusiasts, and individuals managing metabolic conditions. By bridging the gap between clinical diagnostics and everyday wellness, BodyMetRx empowers users to track physiological changes with high accuracy. The company operates multiple locations across the United States, serving as a key resource for preventative health and performance optimization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BodyMetRX.